Stock market week-in-review for 5 large GI companies — Aug. 14-18

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 14 to Aug. 18, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $232.28 on Aug. 14
Peaked: $235.83 on Aug. 14
Closed: $223.92 on Aug. 18
Percent change between Aug 14 to Aug. 18: -3.59 percent

2. Exact Sciences Corp.

Opened: $38.35 on Aug. 14
Peaked: $39.75 on Aug. 15
Closed: $37.87 on Aug. 18
Percent change between Aug 14 to Aug. 18: -1.25 percent

3. Johnson & Johnson

Opened: $133.11 on Aug. 14
Peaked: $134.72 on Aug. 16
Closed: $132.63 on Aug. 18
Percent change between Aug 14 to Aug. 18: -0.36 percent

4. Synergy Pharmaceuticals

Opened: $3.01 on Aug. 14
Peaked: $4.04 on Aug. 16
Closed: $2.92 on Aug. 18
Percent change between Aug 14 to Aug. 18: -2.99 percent

5. Valeant Pharmaceuticals

Opened: $14.12 on Aug. 14
Peaked: $14.81 on Aug. 17
Closed: $14.39 on Aug. 18
Percent change between Aug 14 to Aug. 18: 1.91 percent

More articles on gastroenterology:
Majority of ulcerative colitis patients not achieving clinical, endoscopic remission — 5 key notes
GI leader to know: Dr. Sarah Brendler of the Cascade Endoscopy Center
GI center to know: Cascade Endoscopy Center

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.